CN105936943B - A Rapid and Sensitive RT-LAMP Detection Method for Marburg Virus - Google Patents
A Rapid and Sensitive RT-LAMP Detection Method for Marburg Virus Download PDFInfo
- Publication number
- CN105936943B CN105936943B CN201511002909.1A CN201511002909A CN105936943B CN 105936943 B CN105936943 B CN 105936943B CN 201511002909 A CN201511002909 A CN 201511002909A CN 105936943 B CN105936943 B CN 105936943B
- Authority
- CN
- China
- Prior art keywords
- detection
- marburg virus
- lamp
- detection method
- primer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241001115401 Marburgvirus Species 0.000 title claims abstract description 42
- 238000001514 detection method Methods 0.000 title abstract description 60
- 238000013461 design Methods 0.000 claims abstract description 7
- 238000005516 engineering process Methods 0.000 claims abstract description 5
- 238000007397 LAMP assay Methods 0.000 claims description 17
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- 101150077651 VP35 gene Proteins 0.000 claims description 7
- 238000011896 sensitive detection Methods 0.000 claims description 2
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 18
- 230000003321 amplification Effects 0.000 abstract description 17
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 6
- 230000000007 visual effect Effects 0.000 abstract description 5
- 238000007689 inspection Methods 0.000 abstract description 3
- 230000001404 mediated effect Effects 0.000 abstract description 3
- 230000008676 import Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 22
- 238000006243 chemical reaction Methods 0.000 description 19
- 239000000523 sample Substances 0.000 description 13
- 238000000034 method Methods 0.000 description 11
- 230000035945 sensitivity Effects 0.000 description 10
- 150000007523 nucleic acids Chemical class 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 239000012634 fragment Substances 0.000 description 7
- 238000002123 RNA extraction Methods 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 241000700605 Viruses Species 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 102000039446 nucleic acids Human genes 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 208000035473 Communicable disease Diseases 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 3
- 241001115402 Ebolavirus Species 0.000 description 3
- 241001493065 dsRNA viruses Species 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000011535 reaction buffer Substances 0.000 description 3
- 230000000405 serological effect Effects 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 2
- 201000011001 Ebola Hemorrhagic Fever Diseases 0.000 description 2
- 102000011931 Nucleoproteins Human genes 0.000 description 2
- 108010061100 Nucleoproteins Proteins 0.000 description 2
- 238000010802 RNA extraction kit Methods 0.000 description 2
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 description 2
- 241000710886 West Nile virus Species 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- DEGAKNSWVGKMLS-UHFFFAOYSA-N calcein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(O)=O)CC(O)=O)=C(O)C=C1OC1=C2C=C(CN(CC(O)=O)CC(=O)O)C(O)=C1 DEGAKNSWVGKMLS-UHFFFAOYSA-N 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229910001437 manganese ion Inorganic materials 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 229960002378 oftasceine Drugs 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 241000282693 Cercopithecidae Species 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 208000001490 Dengue Diseases 0.000 description 1
- 206010012310 Dengue fever Diseases 0.000 description 1
- 241000725619 Dengue virus Species 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 108010074933 Ebola virus nucleoprotein VP35 Proteins 0.000 description 1
- 101001065501 Escherichia phage MS2 Lysis protein Proteins 0.000 description 1
- 241000711950 Filoviridae Species 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 108060003393 Granulin Proteins 0.000 description 1
- 206010069767 H1N1 influenza Diseases 0.000 description 1
- 206010061192 Haemorrhagic fever Diseases 0.000 description 1
- 208000002979 Influenza in Birds Diseases 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- WAEMQWOKJMHJLA-UHFFFAOYSA-N Manganese(2+) Chemical compound [Mn+2] WAEMQWOKJMHJLA-UHFFFAOYSA-N 0.000 description 1
- 208000000932 Marburg Virus Disease Diseases 0.000 description 1
- 201000011013 Marburg hemorrhagic fever Diseases 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 101150010086 VP24 gene Proteins 0.000 description 1
- 101150026858 VP30 gene Proteins 0.000 description 1
- 101150036892 VP40 gene Proteins 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 208000003152 Yellow Fever Diseases 0.000 description 1
- 241000710772 Yellow fever virus Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000003766 bioinformatics method Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 208000025729 dengue disease Diseases 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000011901 isothermal amplification Methods 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- -1 pyrophosphate ions Chemical class 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 201000010740 swine influenza Diseases 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 229940051021 yellow-fever virus Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
技术领域technical field
本发明涉及体外诊断试剂技术领域,具体涉及一种快速灵敏的马尔堡病毒RT-LAMP检测方法。The invention relates to the technical field of in vitro diagnostic reagents, in particular to a rapid and sensitive Marburg virus RT-LAMP detection method.
背景技术Background technique
随着全球经济一体化和贸易自由化,国外的医学媒介生物通过先进的交通工具和国际贸易,可以迅速把传染病从一个国家或地区传向全球,造成国际间传播。近年来,新发病毒性传染病在世界各国频频暴发流行,对人类健康带来严重威胁,给社会造成巨大经济损失。比如2003年的严重急性呼吸综合征(SARS)在部分国家和地区的流行,2004年我国和周边国家的禽流感流行,2009年全球甲型H1N1流感疫情,2014年非洲的埃博拉疫情给社会安定、经济建设和人们的生命健康带来了重大的影响。这些新发病毒性传染病的频发给我们敲响了警钟,加强对其的研究和监测以及早预防控制是至关重要的。With global economic integration and trade liberalization, foreign medical vectors can quickly spread infectious diseases from one country or region to the world through advanced means of transportation and international trade, resulting in international spread. In recent years, new viral infectious diseases have frequently broken out in countries all over the world, posing a serious threat to human health and causing huge economic losses to society. For example, the Severe Acute Respiratory Syndrome (SARS) epidemic in some countries and regions in 2003, the avian influenza epidemic in my country and neighboring countries in 2004, the global H1N1 influenza epidemic in 2009, and the Ebola epidemic in Africa in 2014 have given society It has had a major impact on stability, economic construction and people's life and health. The frequent occurrence of these new viral infectious diseases has sounded the alarm for us, and it is very important to strengthen its research and monitoring, as well as early prevention and control.
马尔堡出血热是由马尔堡病毒引起的一种致死率极高的烈性传染病。马尔堡病毒和埃博拉病毒共同构成丝状病毒属,但属两个不同的种系。最早有关马尔堡出血热爆发的记录是在1967年德国马尔堡。据报道当时有31人感染病毒发病,其中7人死亡。这31个感染病毒的人中有25人是由于接触了感染马尔堡病毒的猴子而致病的。之后常发生于一些非洲国家,迄今为止已经发生12次疫情,最严重的一次疫情在2004至2005年发生于安哥拉,累计报告病例374例,其中死亡329例。MARV主要通过密切接触传播,病死率为23%~90%,目前还没有商品化疫苗。Marburg hemorrhagic fever is a highly fatal infectious disease caused by Marburg virus. Marburg virus and Ebola virus together form the filovirus genus, but belong to two different species. The earliest documented outbreak of Marburg haemorrhagic fever was in Marburg, Germany in 1967. At that time, 31 people were reported to have contracted the virus and 7 of them died. Twenty-five of the 31 infected people became ill from contact with monkeys infected with Marburg virus. After that, it often occurred in some African countries. So far, 12 outbreaks have occurred. The most serious outbreak occurred in Angola from 2004 to 2005. A total of 374 cases were reported, including 329 deaths. MARV is mainly transmitted through close contact, with a case fatality rate of 23% to 90%, and there is no commercial vaccine yet.
马尔堡病毒基因组全长约19kb,为单股负链RNA病毒。基因组编码7种病毒蛋白,包括核蛋白(NP)、基质蛋白VP24和VP40、结构蛋白VP30和VP35、依赖RNA的RNA多聚酶(L蛋白)、糖蛋白7(gp7)。The full length of the Marburg virus genome is about 19kb, which is a single-stranded negative-sense RNA virus. The genome encodes seven viral proteins, including nucleoprotein (NP), matrix proteins VP24 and VP40, structural proteins VP30 and VP35, RNA-dependent RNA polymerase (L protein), and glycoprotein 7 (gp7).
目前马尔堡病毒的检测方法主要有病毒分离培养与鉴定、血清中和试验、酶联免疫吸附检测(ELISA)、核酸检测等。对于病毒性疾病来说,病毒分离与培养鉴定是最可靠的检测手段。但是上述病毒分离需在生物安全4级(P4)实验室条件下进行,且所需时间较长,对实验室及实验人员要求极高,也不适用于广泛应用及国境口岸的快速筛查。血清中和试验是病毒血清学检测的主要方法,但同样需要在P4级实验室中进行。同时在2005年的疫情检测中发现ELISA、IgM等血清学或免疫学的检测方法灵敏度较低,假阴性率高,只有核At present, the detection methods of Marburg virus mainly include virus isolation, culture and identification, serum neutralization test, enzyme-linked immunosorbent assay (ELISA), nucleic acid detection, etc. For viral diseases, virus isolation and culture identification are the most reliable detection methods. However, the above-mentioned virus isolation needs to be carried out under the conditions of a biosafety level 4 (P4) laboratory, and it takes a long time, and the requirements for the laboratory and experimenters are extremely high, and it is not suitable for wide application and rapid screening at border ports. Serum neutralization test is the main method for virus serological detection, but it also needs to be carried out in P4 laboratories. At the same time, in the detection of the epidemic in 2005, it was found that ELISA, IgM and other serological or immunological detection methods had low sensitivity and high false negative rate.
酸检测的手段灵敏度得到了一致的认可,但是常规的PCR操作复杂,设备庞大,技术难度比较高,不利于口岸现场诊断以及疫区现场检测。因此迫切需要研发一种新型的快速、简单的核酸检测方法。本发明专利通过研究一种逆转录环介导等温扩增反应(RT-LAMP)方法检测马尔堡病毒。The sensitivity of the acid detection method has been unanimously recognized, but the conventional PCR operation is complicated, the equipment is huge, and the technical difficulty is relatively high, which is not conducive to on-site diagnosis at ports and on-site detection in epidemic areas. Therefore, it is urgent to develop a new rapid and simple nucleic acid detection method. The patent of the present invention detects Marburg virus by studying a reverse transcription loop-mediated isothermal amplification reaction (RT-LAMP) method.
环介导等温扩增法是一种新型恒温核酸扩增方法,其特征是针对目标核酸上的六个区段设计4种或6种引物,然后利用链置换反应在一定的温度下进行反应。4种引物中的2种内引物其3’端和5’端能分别识别靶核酸序列中2个不同区域,并设计成其5’端序列可与由3’端起始的延伸反应所合成的互补链区域退火结合。内引物可形成茎环结构,并进行自我延伸反应,随后在环状结构位置有新的内引物退火结合进行链置换合成反应。二者不断循环重复,实现扩增反应。因此,即便只有1种酶,环介导等温扩增法也可以实现恒温扩增。以RNA为模板时,只需事先加入逆转录酶,就可一步完成cDNA的合成和核酸扩增过程(逆转录环介导等温扩增反应)。The loop-mediated isothermal amplification method is a new type of constant temperature nucleic acid amplification method, which is characterized in that 4 or 6 primers are designed for six segments on the target nucleic acid, and then reacted at a certain temperature by using a strand displacement reaction. The 3' end and 5' end of the 2 internal primers among the 4 primers can respectively recognize two different regions in the target nucleic acid sequence, and the 5' end sequence can be synthesized by the extension reaction starting from the 3' end Annealing of complementary strand regions. The inner primer can form a stem-loop structure and undergo a self-extension reaction, and then a new inner primer anneals at the position of the loop structure to perform a strand displacement synthesis reaction. The two are continuously repeated in a cycle to realize the amplification reaction. Therefore, even with only one enzyme, the loop-mediated isothermal amplification method can achieve isothermal amplification. When RNA is used as a template, cDNA synthesis and nucleic acid amplification can be completed in one step by adding reverse transcriptase in advance (reverse transcription loop mediated isothermal amplification reaction).
环介导等温扩增基因扩增法的特征是在合成大量核酸的同时,还会生成大量副产物焦磷酸离子。荧光目测试剂中所含的钙黄绿素初始因与锰离子结合而处于荧光淬灭状态。但随着环介导等温扩增反应的进行,因为被反应副产物焦磷酸离子夺去结合的锰离子,钙黄绿素恢复游离从而发出荧光。进而与反应液中的镁离子相结合,使荧光得到增强。根据这一原理,可以通过荧光目视检测轻松判断是否发生了环介导等温扩增。The characteristic of the loop-mediated isothermal amplification gene amplification method is that while synthesizing a large amount of nucleic acid, a large amount of by-product pyrophosphate ions are also generated. Calcein contained in the fluorescent objective reagent is initially in a state of fluorescence quenching due to binding with manganese ions. However, with the progress of the loop-mediated isothermal amplification reaction, because the pyrophosphate ion by the reaction by-product deprives the bound manganese ion, calcein becomes free and emits fluorescence. Furthermore, it combines with magnesium ions in the reaction solution to enhance the fluorescence. According to this principle, the occurrence of loop-mediated isothermal amplification can be easily judged by visual detection of fluorescence.
环介导的等温扩增(LAMP)方法具备快速、高效、特异性强、灵敏度高等优点。LAMP方法速度快,对实验要求不高,只需要一台水浴锅即可,不需要无菌操作,在短时间内可以检测大量样品,适于实验室血清诊断、海关检疫及大规模疫病普查。此外,LAMP检测法比较灵敏,而且结果也较为可靠。The loop-mediated isothermal amplification (LAMP) method has the advantages of rapidity, high efficiency, strong specificity, and high sensitivity. The LAMP method is fast and does not require high experimental requirements. It only needs a water bath, does not require aseptic operation, and can detect a large number of samples in a short period of time. It is suitable for laboratory serological diagnosis, customs quarantine, and large-scale disease surveys. In addition, the LAMP assay is more sensitive and the results are more reliable.
目前对于马尔堡病毒的分子生物学检测主要是通过PCR技术,本发明根据马尔堡病毒的特异性基因片段V35,设计了一组特异性引物,采用RT-LAMP的方法可以在短短的半小时到一小时内检测扩增片段,操作上只要一台恒温水浴锅即可,方法简单,灵敏度高,时间短。本发明的检测方法可运用于马尔堡病毒快速灵敏的检测,作为口岸快速筛查的方法,提高检测的准确性和时效性,可大大地降低检测的周期。At present, the molecular biology detection of Marburg virus is mainly through PCR technology. According to the specific gene fragment V35 of Marburg virus, the present invention designs a group of specific primers. To detect the amplified fragment within one hour, only a constant temperature water bath is required for operation, the method is simple, the sensitivity is high, and the time is short. The detection method of the present invention can be applied to the rapid and sensitive detection of Marburg virus, and can be used as a rapid screening method at ports to improve the accuracy and timeliness of detection and greatly reduce the detection cycle.
发明内容Contents of the invention
本发明所要解决的技术问题之一是提供一种快速灵敏的马尔堡病毒RT-LAMP检测方法,本发明能对马尔堡病毒基因进行快速灵敏的检测,通过本发明可大幅度提高进出口口岸一线检验检疫人员的检测效率,既可减少工作量、又可最大限度地解决传统检测方法可能存在的阳性漏检问题,从而最大限度地防止疫情的发生和国外马尔堡病毒的传入。One of the technical problems to be solved by the present invention is to provide a fast and sensitive RT-LAMP detection method for Marburg virus. The detection efficiency of inspection and quarantine personnel can not only reduce the workload, but also solve the problem of positive and missed detection that may exist in traditional detection methods to the greatest extent, so as to prevent the occurrence of epidemics and the introduction of foreign Marburg virus to the greatest extent.
本发明所提供的快速灵敏的马尔堡病毒RT-LAMP检测方法,包括如下步骤:The fast and sensitive Marburg virus RT-LAMP detection method provided by the present invention comprises the following steps:
(1)全血标本进行RNA液提取;(1) RNA extraction from whole blood samples;
(2)RT-LAMP扩增:(2) RT-LAMP amplification:
a.RT-PCR反应体系包括:2×反应缓冲液(RM),待测样本基因特异性引物,dd H2O,酶溶液,RNA提取液,荧光目视试剂;a. The RT-PCR reaction system includes: 2× reaction buffer (RM), gene-specific primers for the sample to be tested, dd H2O, enzyme solution, RNA extraction solution, and fluorescent visual reagents;
b.将PCR反应液加入PCR管,放入63℃的恒温仪器或LAMP检测仪,恒温反应的反应条件:63℃反应60min。;b. Add the PCR reaction solution into the PCR tube, put it into a 63°C constant temperature instrument or a LAMP detector, and the reaction conditions of the constant temperature reaction: 63°C for 60 minutes. ;
(3)结果判读:阴性对照颜色为棕色,阳性样本为绿色,如果用LAMP检测仪则有明显的扩增曲线。(3) Interpretation of the results: the color of the negative control is brown, and the color of the positive sample is green. If a LAMP detector is used, there will be an obvious amplification curve.
步骤(1)中所述的RNA提取可使用血液样本基因组RNA提取试剂盒提取RNA。取100ul全血样本,按照试剂盒说明书中的提取步骤提取RNA;The RNA extraction described in step (1) can use blood sample genome RNA extraction kit to extract RNA. Take 100ul whole blood sample, and extract RNA according to the extraction steps in the kit manual;
步骤(2)中所述的PCR反应体系为:2X反应缓冲液12.5μl,特异性引物混合液2.5μl,酶液1.0μl,dd H2O 3.0μl,荧光目测试剂1.0μl,RNA提取液5μl。The PCR reaction system described in step (2) is: 12.5 μl of 2X reaction buffer, 2.5 μl of specific primer mixture, 1.0 μl of enzyme solution, 3.0 μl of dd H2O, 1.0 μl of fluorescent visual reagent, and 5 μl of RNA extraction solution.
步骤(2)中所述的待测样本基因特异性引物为以马尔堡病毒特有基因VP35基因为靶基因、基于环介导恒温扩增技术设计的各三对引物:内引物FIP/BIP、外引物F3/B3、环引物LF/LB,对VP35基因在多种马尔堡病毒中的序列进行比较,选取同源性最高的一段设计引物可提高马尔堡病毒检出的特异性。三对特异性引物为:The gene-specific primers for the sample to be tested described in step (2) are three pairs of primers designed based on the loop-mediated constant temperature amplification technology with the specific gene VP35 gene of Marburg virus as the target gene: the inner primer FIP/BIP, the outer primer Primers F3/B3 and loop primers LF/LB were used to compare the sequences of VP35 gene in various Marburg viruses, and to select a section with the highest homology to design primers to improve the specificity of Marburg virus detection. The three pairs of specific primers are:
内引物-FIP:5’-GTTTCCTCACTGAGTTCAAGGACCCGGTTAAAAATGCAACAACAG-3’ (SEQID NO 1)Internal primer-FIP: 5'-GTTCCTCACTGAGTTCAAGGACCCGGTTAAAAATGCAACAACAG-3' (SEQ ID NO 1)
内引物-BIP:5’-CAAGCCAAACCTCTCAGCCAGGATGTGGAATGGAGTGT-3’ (SEQ ID NO 2)Inner primer-BIP: 5'-CAAGCCAAACCTCTCAGCCAGGATGTGGAATGGAGTGT-3' (SEQ ID NO 2)
外引物-F3:5’-AGCTTGTAGTAAGGGGACTA-3’ (SEQ ID NO 3)Outer primer-F3: 5'-AGCTTGTAGTAAGGGGACTA-3' (SEQ ID NO 3)
外引物-B3:5’-GTAAGCAATTTTTGAAAGGACC-3’ (SEQ ID NO 4)Outer primer-B3: 5'-GTAAGCAATTTTTGAAAGGACC-3' (SEQ ID NO 4)
环引物-LF: 5’-ACATCTTGTCGGCTGCAT-3’ (SEQ ID NO 5)Loop Primer-LF: 5'-ACATCTTGTCGGCTGCAT-3' (SEQ ID NO 5)
环引物-LB:5’-TTACCCATCTACCCGGCAA-3’ (SEQ ID NO 6)Loop Primer-LB:5'-TTACCCATCTACCCGGCAA-3' (SEQ ID NO 6)
本发明针对马尔堡病毒特有基因,设计三对特异性引物,使得本发明的检测方法检测马尔堡病毒基因的准确率更高,可以灵敏、特异地检测马尔堡病毒,与常规PCR方法比较,检测灵敏度和特异性均明显高于常规方法。本发明的检测方法不仅可以满足日常疫情安全检测的要求,也可以满足临床样品的检测要求。本发明与现有检测方法相比,反应只需要在一台小型LAMP扩增仪或者恒温水浴中即可完成,检测结果可以通过目测的方法检测到,大大缩减了检测的时间和复杂性,检测设备简单易于携带,大大提高了当前的检测能力。而从样品采集到检测总时间完全可以在1小时内完成,有益于快速准确的检测马尔堡病毒。The present invention designs three pairs of specific primers for the specific gene of Marburg virus, so that the detection method of the present invention has higher accuracy in detecting Marburg virus gene, and can detect Marburg virus sensitively and specifically. Compared with the conventional PCR method, the detection Sensitivity and specificity were significantly higher than conventional methods. The detection method of the present invention can not only meet the requirements of daily epidemic safety detection, but also meet the detection requirements of clinical samples. Compared with the existing detection methods, the present invention only needs to complete the reaction in a small-scale LAMP amplification instrument or a constant temperature water bath, and the detection results can be detected by visual inspection, which greatly reduces the time and complexity of detection. The equipment is simple and easy to carry, which greatly improves the current detection capability. The total time from sample collection to detection can be completed within 1 hour, which is beneficial to the rapid and accurate detection of Marburg virus.
附图说明Description of drawings
图1为实施例1马尔堡病毒RT-LAMP检测结果。Figure 1 is the detection result of Marburg virus RT-LAMP in Example 1.
左边图为右边图的检测管在LAMP扩增仪检测到的信号强度,右图为肉眼观测到的颜色变化,右图上面的数字代表的copies/ul。The left picture shows the signal intensity detected by the detection tube in the right picture in the LAMP amplification instrument, the right picture shows the color change observed by the naked eye, and the numbers on the right picture represent copies/ul.
图2为实施例1马尔堡病毒RT-LAMP检测方法马尔堡病毒V35阳性样本检测特异性结果。Fig. 2 is the detection specificity result of the Marburg virus V35 positive sample of the Marburg virus RT-LAMP detection method in Example 1.
左为不同样品扩增产物荧光强度,右为不同柱状图样本名称。The left is the fluorescence intensity of amplification products of different samples, and the right is the sample names of different histograms.
图3为实施例1马尔堡病毒RT-LAMP检测方法灵敏性实验结果。Fig. 3 is the result of the sensitivity experiment of the Marburg virus RT-LAMP detection method in Example 1.
左为各柱形图的样本浓度,右为不同浓度样本的扩增产物荧光强度。The left is the sample concentration of each bar graph, and the right is the fluorescence intensity of the amplification products of samples with different concentrations.
图4为实施例1马尔堡病毒RT-LAMP检测方法检测时间测定结果。Fig. 4 is the detection time measurement result of the Marburg virus RT-LAMP detection method in Example 1.
下面结合具体实施例,进一步阐述本发明。应理解,这些实施例仅用于说明本发明而不用于限制本发明的范围。此外应理解,在阅读了本发明讲授的内容之后,本领域技术人员可以对本发明作各种改动或修改,这些等价形式同样落于本申请所附权利要求书所限定的范围。Below in conjunction with specific embodiment, further illustrate the present invention. It should be understood that these examples are only used to illustrate the present invention and are not intended to limit the scope of the present invention. In addition, it should be understood that after reading the teachings of the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms also fall within the scope defined by the appended claims of the present application.
实施例1马尔堡病毒RT-LAMP检测方法的特异性与灵敏性Example 1 Specificity and sensitivity of Marburg virus RT-LAMP detection method
一、实验步骤1. Experimental steps
1.马尔堡病毒、埃博拉病毒RNA的体外合成1. In vitro synthesis of Marburg virus and Ebola virus RNA
利用经生物信息学方法分析已公开发表的马尔堡病毒安哥拉株基因组序列(Ang1379c),人工合成含特异检测马尔堡病毒VP35片段(约600bp)克隆于PCR cloning vector(TOPO TA cloning kit)上,用质粒DNA提取试剂盒纯化质粒DNA,测序证实插入片段正确后进行体外转录:先用Not I酶切质粒使线性化以排除下游RNA产物,再用MAXIscript T7Kit进行体外转录,生成目的RNA,然后用TurboDNase进行DNase处理,去除未转录完的质粒DNA模板,最后用乙醇沉淀,提纯RNA产物,即为阳性对照RNA模板,保存于-70℃超低温冰箱待用。同样的方法得到埃博拉病毒VP35的RNA片段。Using bioinformatics methods to analyze the genome sequence (Ang1379c) of the published Marburg virus Angola strain, the artificially synthesized fragment (about 600 bp) containing the specific detection Marburg virus VP35 was cloned on the PCR cloning vector (TOPO TA cloning kit), and used Plasmid DNA extraction kit to purify the plasmid DNA, sequence to confirm that the insert is correct, and then perform in vitro transcription: First, digest the plasmid with Not I to linearize it to exclude downstream RNA products, then use MAXIscript T7Kit for in vitro transcription to generate target RNA, and then use TurboDNase Perform DNase treatment to remove untranscribed plasmid DNA templates, and finally use ethanol precipitation to purify the RNA product, which is the positive control RNA template, and store it in a -70°C ultra-low temperature refrigerator until use. The same method was used to obtain the RNA fragment of Ebola virus VP35.
2.血液样本的采集2. Collection of blood samples
取口岸检测病人的全血样本1.0ml,离心处理得到血清。Take 1.0ml of whole blood sample from the patient for port testing, and centrifuge to obtain serum.
3.基因组RNA的提取3. Genomic RNA Extraction
使用血液样本基因组RNA提取试剂盒(离心柱型,Qiagen公司)提取登革热RNA、黄热RNA、西尼罗病毒RNA。取100uL血清样本,按照试剂盒说明书中的提取步骤提取RNA。Genomic RNA extraction kit from blood samples (spin column type, Qiagen) was used to extract dengue fever RNA, yellow fever RNA, and West Nile virus RNA. Take 100uL serum sample, and extract RNA according to the extraction steps in the kit instruction manual.
4.RNA浓度的测定4. Determination of RNA Concentration
通过Nanodrop 2000c测定RNA片段的浓度,并根据RNA片段的大小计算RNA的拷贝数。The concentration of RNA fragments was determined by Nanodrop 2000c, and the copy number of RNA was calculated according to the size of RNA fragments.
5.靶基因的扩增5. Amplification of target genes
5.1引物的设计5.1 Design of primers
以马尔堡病毒特有基因VP35基因为靶基因、基于环介导恒温扩增技术设计的各三对引物:内引物FIP/BIP、外引物F3/B3、环引物LF/LB,对VP35基因在多种马尔堡病毒中的序列进行比较,选取同源性最高的一段设计引物可提高马尔堡病毒检出的特异性。三对特异性引物为:Three pairs of primers were designed based on the loop-mediated constant temperature amplification technology, with the VP35 gene unique to Marburg virus as the target gene: the inner primer FIP/BIP, the outer primer F3/B3, and the loop primer LF/LB. To compare the sequences in different Marburg viruses, select the one with the highest homology to design primers to improve the specificity of Marburg virus detection. The three pairs of specific primers are:
内引物-FIP:5’-GTTTCCTCACTGAGTTCAAGGACCCGGTTAAAAATGCAACAACAG-3’ (SEQID NO 1)Internal primer-FIP: 5'-GTTCCTCACTGAGTTCAAGGACCCGGTTAAAAATGCAACAACAG-3' (SEQ ID NO 1)
内引物-BIP:5’-CAAGCCAAACCTCTCAGCCAGGATGTGGAATGGAGTGT-3’ (SEQ ID NO 2)Inner primer-BIP: 5'-CAAGCCAAACCTCTCAGCCAGGATGTGGAATGGAGTGT-3' (SEQ ID NO 2)
外引物-F3:5’-AGCTTGTAGTAAGGGGACTA-3’ (SEQ ID NO 3)Outer primer-F3: 5'-AGCTTGTAGTAAGGGGACTA-3' (SEQ ID NO 3)
外引物-B3:5’-GTAAGCAATTTTTGAAAGGACC-3’ (SEQ ID NO 4)Outer primer-B3: 5'-GTAAGCAATTTTTGAAAGGACC-3' (SEQ ID NO 4)
环引物-LF: 5’-ACATCTTGTCGGCTGCAT-3’ (SEQ ID NO 5)Loop Primer-LF: 5'-ACATCTTGTCGGCTGCAT-3' (SEQ ID NO 5)
环引物-LB:5’-TTACCCATCTACCCGGCAA-3’ (SEQ ID NO 6)Loop Primer-LB:5'-TTACCCATCTACCCGGCAA-3' (SEQ ID NO 6)
5.2反应体系5.2 Reaction system
在LAMP扩增仪上进行扩增,扩增体系为:2X反应缓冲液12.5μl,特异性引物混合液2.5μl,酶液1.0μl,dd H2O 3.0μl,荧光目测试剂1.0μl,RNA提取液5μl。Amplify on a LAMP amplification instrument. The amplification system is: 12.5 μl of 2X reaction buffer, 2.5 μl of specific primer mixture, 1.0 μl of enzyme solution, 3.0 μl of dd H 2 O, 1.0 μl of fluorescent visual reagent, RNA Extraction solution 5μl.
恒温反应的反应条件:63℃反应60min。Reaction conditions for constant temperature reaction: 60°C for 60 minutes.
6.结果判读6. Interpretation of results
a,在LAMP扩增仪上进行扩增,通过扩增柱状图进行判断a, Amplify on the LAMP amplification instrument, judge by the amplification histogram
b,在恒温仪器中进行扩增,通过扩增体系颜色变化判断,阴性对照为棕色,阳性为绿色。b, Amplified in a constant temperature instrument, judged by the color change of the amplification system, the negative control is brown, and the positive is green.
7.检测体系特异性7. Detection system specificity
根据RNA浓度的测定,得到10E+6copies/ul与1copies/ul两个马尔堡病毒V35核酸片段浓度样本,分别以两个浓度的马尔堡病毒VP35基因RNA、埃博拉病毒V35基因片段、登革热病毒RNA、黄热病毒RNA、西尼罗病毒RNA为模板按照5.2步骤进行检测,观察其特异性。According to the determination of RNA concentration, two Marburg virus V35 nucleic acid fragment concentration samples of 10E+6copies/ul and 1copies/ul were obtained, respectively with two concentrations of Marburg virus VP35 gene RNA, Ebola virus V35 gene fragment, and dengue virus RNA, yellow fever virus RNA, and West Nile virus RNA were used as templates for detection according to step 5.2, and their specificity was observed.
8.体系灵敏性检测8. System sensitivity test
按照5.2的方法对各稀释度进行测定,并计算检测方法的检测下限。Measure each dilution according to the method in 5.2, and calculate the detection limit of the detection method.
9.检测时间:根据检测的曲线,确定检测时间9. Detection time: Determine the detection time according to the detection curve
二、结果2. Results
1.马尔堡病毒的检测能力1. Detection ability of Marburg virus
用体外合成的马尔堡RNA样品进行了实验,结果见图1。通过实验发现,从1copy/ul到109copies/ul的样品都可以检测到,并且检测结果通过机器检测荧光强度与肉眼观察反应液颜色的变化结果一致。充分说明该方法操作简单,只要有一台水浴锅就可以进行反应,并观察结果。与机器采集荧光强度相比,可能不如机器精准。Experiments were performed with in vitro synthesized Marburg RNA samples and the results are shown in Figure 1. It is found through experiments that samples ranging from 1 copy/ul to 10 9 copies/ul can be detected, and the detection result is consistent with the result of the color change of the reaction solution observed by the naked eye through the machine-detected fluorescence intensity. It fully demonstrates that the method is simple to operate, as long as there is a water bath, the reaction can be carried out and the results can be observed. Compared with the fluorescence intensity collected by the machine, it may not be as accurate as the machine.
2.样本特异性试验:2. Sample specificity test:
如图2显示,两个马尔堡病毒V35核酸片段10E+6copies/ul与1copies/ul高低两个浓度均可以检测到,而其他病毒RNA及埃博拉人工合成V35核酸片段均未检测到。As shown in Figure 2, two Marburg virus V35 nucleic acid fragments, 10E+6copies/ul and 1copies/ul, can be detected at both high and low concentrations, while other viral RNAs and Ebola artificially synthesized V35 nucleic acid fragments were not detected.
3,灵敏性实验3. Sensitivity experiment
分别检测100copies/ul、10copies/ul、1copies/ul、0.1copies/ul、0.01copies/ul、0.001copies/ul及0.0001copies/ul不同稀释浓度梯度的样本,进行方法灵敏性实验,如图3显示,可以检测到1copies/ul浓度的样本,样本量为5ul,检测下限5copies。Detect samples with different dilution concentration gradients of 100copies/ul, 10copies/ul, 1copies/ul, 0.1copies/ul, 0.01copies/ul, 0.001copies/ul and 0.0001copies/ul respectively, and conduct method sensitivity experiments, as shown in Figure 3 , can detect samples with a concentration of 1copies/ul, the sample volume is 5ul, and the detection limit is 5copies.
4,检测时间测定4. Detection Time Determination
当10、100copies/ul的样本在28min时可以检测到,而1copy/ul样本在42min时可以检测到,具体见图4。另外其他数据显示10E+6copies/ul样本甚至可以在16min时可以检测到,具有极好的时效性。When 10, 100copies/ul samples can be detected at 28min, and 1copy/ul samples can be detected at 42min, see Figure 4 for details. In addition, other data show that 10E+6copies/ul samples can even be detected in 16 minutes, which has excellent timeliness.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511002909.1A CN105936943B (en) | 2015-12-28 | 2015-12-28 | A Rapid and Sensitive RT-LAMP Detection Method for Marburg Virus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511002909.1A CN105936943B (en) | 2015-12-28 | 2015-12-28 | A Rapid and Sensitive RT-LAMP Detection Method for Marburg Virus |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105936943A CN105936943A (en) | 2016-09-14 |
CN105936943B true CN105936943B (en) | 2019-09-27 |
Family
ID=57153026
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201511002909.1A Active CN105936943B (en) | 2015-12-28 | 2015-12-28 | A Rapid and Sensitive RT-LAMP Detection Method for Marburg Virus |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105936943B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106636469A (en) * | 2017-01-12 | 2017-05-10 | 中国人民解放军军事医学科学院微生物流行病研究所 | RPA technology-based marburg virus detection kit and application thereof |
CN109504808A (en) * | 2019-01-11 | 2019-03-22 | 福建出入境检验检疫局检验检疫技术中心 | Monkey Marburg virus real-time fluorescent RT-PCR method for detecting |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102140531A (en) * | 2010-12-24 | 2011-08-03 | 中国检验检疫科学研究院 | Novel Marburg virus fluorescent quantitative PCR (Polymerase Chain Reaction) detection method and Marburg virus PCR detection system |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1856280A4 (en) * | 2005-01-12 | 2009-09-09 | Applera Corp | Compositions, methods, and kits for selective amplification of nucleic acids |
-
2015
- 2015-12-28 CN CN201511002909.1A patent/CN105936943B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102140531A (en) * | 2010-12-24 | 2011-08-03 | 中国检验检疫科学研究院 | Novel Marburg virus fluorescent quantitative PCR (Polymerase Chain Reaction) detection method and Marburg virus PCR detection system |
Non-Patent Citations (3)
Title |
---|
Development and evaluation of a simple assay for Marburg virus detection using a reverse transcription-loop-mediated isothernal amplification method;Yohei Kurosaki et al.;《Clinical Microbiology》;20100731;第48卷(第7期);摘要部分、第2332页左栏第4段-右栏第2段和表1 * |
Marburg hemorrhagic fever associated with multiple genetic lineages of virus;Daniel G. Bausch et al.;《The New England journal of medicine》;20060831(第355期);第912页左栏第2段-右栏第2段 * |
马尔堡病毒的实时荧光RT-PCR检测方法研究;洪烨;《中国国境卫生检疫杂志》;20111231;第34卷(第6期);第435-438页 * |
Also Published As
Publication number | Publication date |
---|---|
CN105936943A (en) | 2016-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103074446B (en) | Human immunodeficiency virus (HIV) nucleic acid detection kit | |
Li et al. | Rapid detection of peste des petits ruminants virus by a reverse transcription loop-mediated isothermal amplification assay | |
CN108559792A (en) | A kind of real-time fluorescence quantitative PCR primer, kit and the method for detection slow virus virus titer | |
Park et al. | Loop-mediated isothermal amplification for the rapid detection of Chrysanthemum chlorotic mottle viroid (CChMVd) | |
CN103740863B (en) | RT-LAMP (Reverse Transcription Loop-Mediated Isothermal Amplification) kit for detecting avian influenza virus subtype H7N9 | |
CN102965451A (en) | Group A rotavirus real-time isothermal amplification detection kit, primers and probe thereof | |
CN107177700A (en) | A kind of LAMP primer group, kit and detection method for detecting cucumber mosaic virus | |
CN106636454B (en) | A real-time fluorescent multiplex RT-PCR method for simultaneous detection of human coronaviruses 229E, OC43, NL63 and HKU1 | |
CN107164566B (en) | LAMP primer group, kit and detection method for detecting lily mottle virus | |
CN105936943B (en) | A Rapid and Sensitive RT-LAMP Detection Method for Marburg Virus | |
CN113667668B (en) | HBV detection based on CRISPR/Cas system | |
Kuan et al. | Use of Reverse Transcription Loop‐Mediated Isothermal Amplification for the Detection of Z ucchini yellow mosaic virus | |
CN102154519A (en) | General TaqMan real-time fluorescent quantitative polymerase chain reaction (PCR) detection kit for dengue virus | |
CN114540526A (en) | Primer, probe and method for typing detection of five input plasmodium | |
CN103498010B (en) | Primer and kit for rapidly detecting tomato chlorosis virus (ToCV) and application thereof | |
CN108060271B (en) | Loop-mediated isothermal amplification dengue virus detection method | |
Zang et al. | Reverse transcription recombinase polymerase amplification assay for rapid detection of the cucurbit chlorotic yellows virus | |
CN103484563A (en) | Kit used for detecting sheeppox virus | |
CN103952495B (en) | A kind of LAMP detection method of mandarin fish infectious spleen and kidney necrosis virus | |
Daskou et al. | A colorimetric IsoPCR for the rapid and sensitive visual detection of high-risk HPV16 in clinical samples with hydroxynaphthol blue | |
CN116479189A (en) | Whole-gene capturing method, primer combination and kit for syncytial virus subtype B | |
CN108676921A (en) | A kind of LAMP primer group and detection method and its application for aviadenovirus detection | |
CN113817870A (en) | Primer composition for simultaneous detection of seven respiratory tract-associated viruses and its application | |
JP2007514440A (en) | Sensitive and specific test to detect SARS coronavirus | |
Chen et al. | Development of a concentration method for detection of tobacco mosaic virus in irrigation water |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |